Express Scripts (ESRX)

Add a New Bulls Reason Company: Express Scripts (ESRX) Current price: Headline: (100 character max) Analysis: Cancel 100% agree 8 votes edit Increasing use of Generic Drugs Top Contributor: Sam Shepard | Created when NASDAQ:ESRX was $64.30 | Edit | History ESRX earns a greater margin on the sales of generic drugs versus branded drugs; with many drugs loosing their patent exclusivity in the next coming years, this could beneficially affect ESRX’s operating income. (100 character max) Cancel 0% agree 0 votes edit The Baby Boomers Top Contributor: Sam Shepard | Created when NASDAQ:ESRX was $64.30 | Edit | History The aging of the US population will increase demand for pharmacuetical and ESRX stand to gain from this demographic change. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.